Hills Bank & Trust Co. Raises Stake in Zimmer Biomet Holdings Inc (ZBH)

Hills Bank & Trust Co. boosted its stake in shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) by 5.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,264 shares of the medical equipment provider’s stock after buying an additional 540 shares during the period. Hills Bank & Trust Co.’s holdings in Zimmer Biomet Holdings were worth $1,447,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in ZBH. BlackRock Inc. increased its stake in Zimmer Biomet Holdings by 4,042.4% in the first quarter. BlackRock Inc. now owns 16,740,383 shares of the medical equipment provider’s stock valued at $2,044,168,000 after buying an additional 16,336,262 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Zimmer Biomet Holdings by 3.7% in the first quarter. Vanguard Group Inc. now owns 13,041,411 shares of the medical equipment provider’s stock worth $1,592,488,000 after buying an additional 464,916 shares in the last quarter. State Street Corp increased its position in shares of Zimmer Biomet Holdings by 2.4% in the first quarter. State Street Corp now owns 8,193,165 shares of the medical equipment provider’s stock worth $1,000,463,000 after buying an additional 191,747 shares in the last quarter. Nordea Investment Management AB increased its position in shares of Zimmer Biomet Holdings by 25.0% in the first quarter. Nordea Investment Management AB now owns 4,931,281 shares of the medical equipment provider’s stock worth $602,159,000 after buying an additional 987,398 shares in the last quarter. Finally, First Manhattan Co. increased its position in shares of Zimmer Biomet Holdings by 13.5% in the first quarter. First Manhattan Co. now owns 2,565,370 shares of the medical equipment provider’s stock worth $333,549,000 after buying an additional 305,668 shares in the last quarter. Hedge funds and other institutional investors own 82.84% of the company’s stock.

Shares of Zimmer Biomet Holdings Inc (NYSE ZBH) traded down 0.93% during midday trading on Friday, reaching $111.38. The company had a trading volume of 1,036,099 shares. The stock has a market capitalization of $22.52 billion, a PE ratio of 31.72 and a beta of 1.20. The company’s 50 day moving average price is $122.63 and its 200 day moving average price is $121.15. Zimmer Biomet Holdings Inc has a 52-week low of $95.63 and a 52-week high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last released its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.10 by $0.02. The firm had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 7.31% and a net margin of 9.42%. The company’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.02 EPS. Equities research analysts expect that Zimmer Biomet Holdings Inc will post $8.24 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 22nd will be paid a dividend of $0.24 per share. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 dividend on an annualized basis and a yield of 0.86%. Zimmer Biomet Holdings’s dividend payout ratio is presently 27.59%.

TRADEMARK VIOLATION NOTICE: “Hills Bank & Trust Co. Raises Stake in Zimmer Biomet Holdings Inc (ZBH)” was published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.com-unik.info/2017/08/19/hills-bank-trust-co-has-1-45-million-stake-in-zimmer-biomet-holdings-inc-zbh-updated-updated-updated.html.

ZBH has been the subject of a number of recent research reports. Needham & Company LLC boosted their target price on shares of Zimmer Biomet Holdings from $151.00 to $153.00 and gave the stock a “strong-buy” rating in a report on Friday, April 28th. Oppenheimer Holdings, Inc. set a $132.00 target price on shares of Zimmer Biomet Holdings and gave the stock a “buy” rating in a report on Friday, April 28th. Goldman Sachs Group, Inc. (The) initiated coverage on shares of Zimmer Biomet Holdings in a report on Tuesday, May 16th. They issued a “sell” rating and a $92.00 target price for the company. Wells Fargo & Company downgraded shares of Zimmer Biomet Holdings from an “outperform” rating to a “market perform” rating in a report on Friday, April 28th. Finally, Zacks Investment Research downgraded shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $136.90.

In other Zimmer Biomet Holdings news, insider Sang Yi sold 17,731 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $124.56, for a total value of $2,208,573.36. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $121.74, for a total value of $2,067,875.64. The disclosure for this sale can be found here. Company insiders own 1.07% of the company’s stock.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

What are top analysts saying about Zimmer Biomet Holdings Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Zimmer Biomet Holdings Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit